Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Thermedical is raising $9,500,000.00 in new funding. Sources indicate as part of senior management President, Michael Curley played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Thermedical

Thermedical is developing a proprietary thermal ablation therapy that can treat significantly larger tissue volumes using a single device than conventional technology. The Company is focused on the treatment and cure of Ventricular Tachycardia (VT), an irregular heartbeat that can lead to sudden cardiac arrest, and the treatment of soft tissue conditions. Both of these disease states require a tool that can predictably and efficiently ablate a much larger volume of tissue than conventional technology. Our Thermedical Ablation System employs Saline-Enhanced Radio Frequency (SERF) energy to overcome the challenges of traditional ablation tools and to treat large volumes of tissue in a more efficient manner.

To learn more about Thermedical, visit http://www.thermedical.com/

Contact:
Michael Curley, President
781-373-3688
https://www.linkedin.com/in/michael-curley-b98a7611/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved